Clinical Trial Update: Rivastigmine as a Treatment for Methamphetamine Dependence [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating rivastigmine for methamphetamine dependence has completed, with Baylor College of Medicine as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence
• Substance Use Disorder

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Methamphetamine Dependence, Substance Abuse | Phase 1 | Status: COMPLETED